In Section A, contributors will obtain unique doses and schedules of oral ABBV-744 pill to recognize Harmless dosing regimen. Added contributors will likely be enrolled for the discovered monotherapy dosign routine. In Section B, contributors will acquire oral ruxolitinib and ABBV-744 will probably be specified as "include-on" therapy. In Section https://robinsoni555yzm6.blogmazing.com/profile